APA (7th ed.) Citation

SJ, S., BA, B., ES, C., DE, C., P, D., PS, F., . . . MB, L. (2022). Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): A randomised, multicentre, blinded, sham-controlled trial. Lancet (London, England), 399(10330), 1130. https://doi.org/10.1016/S0140-6736(22)00016-2

Chicago Style (17th ed.) Citation

SJ, Shah, et al. "Atrial Shunt Device for Heart Failure with Preserved and Mildly Reduced Ejection Fraction (REDUCE LAP-HF II): A Randomised, Multicentre, Blinded, Sham-controlled Trial." Lancet (London, England) 399, no. 10330 (2022): 1130. https://doi.org/10.1016/S0140-6736(22)00016-2.

MLA (9th ed.) Citation

SJ, Shah, et al. "Atrial Shunt Device for Heart Failure with Preserved and Mildly Reduced Ejection Fraction (REDUCE LAP-HF II): A Randomised, Multicentre, Blinded, Sham-controlled Trial." Lancet (London, England), vol. 399, no. 10330, 2022, p. 1130, https://doi.org/10.1016/S0140-6736(22)00016-2.